MAPT and Parkinson disease: In summary, our findings suggest that integrated plasma levels of α-synuclein, total tau, p-Tau181, and Aβ42 improve the differential diagnosis of PD from APS (PSP, CBD, DLB, and FTD-P) and FTD.